Company Analysis

Pulmonx Corporation (LUNG)

Nasdaq: LUNG · Surgical & Medical Instruments & Apparatus · Redwood City, CA · filing with the SEC since 2003
Grade5.6
◀ Past 7.0● Present 5.0▶ Future 4.9
1 est.

Who runs Pulmonx Corporation

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
French Glendon E. III
President and CEO. First filing Sep 2020, latest Sep 3, 2026, 41 filings in all.
Officers reporting now
7
of 13 people with a filing in the last fifteen months
Directors reporting now
6
16 people on the record since 2020
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
French Glendon E. IIIPresident and CEOSep 2020Sep 3, 202610 · $300,000
Radhakrishnan SrikanthChief Science & Techn. OfficerDec 2025Sep 3, 202612 · $100,000
Rose Geoffrey BeranChief Commercial OfficerSep 2020Sep 3, 202616 · $100,000
Lehman David AaronGeneral CounselOct 2020Sep 3, 202616 · $100,000
Sung DerrickCOO and CFOSep 2020Dec 3, 2025none
Williamson Steven S.PRESIDENT AND CEOMar 2024Sep 3, 2025none
Joshi MehulChief Financial Officer & PAOApr 2024Sep 3, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Burns Thomas WilliamdirectorOct 2020Jun 9, 2026none
Ferrari Richard MdirectorSep 2020Jun 9, 2026none
Florin Daniel PdirectorSep 2020Jun 9, 20261 · $0.00
Mead Dana G Jr.directorSep 2020Jun 9, 2026none
Melenikiotou GeorgiadirectorOct 2020Jun 9, 2026none
Sullivan TiffanydirectorAug 2021Jun 9, 2026none
Earlier names on the record4, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton LUNG · research, not advice